Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Martin McCarter

Concepts (810)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Melanoma
52
2025
764
7.680
Why?
Esophageal Neoplasms
29
2025
351
5.030
Why?
Skin Neoplasms
34
2024
805
4.530
Why?
Adenocarcinoma
29
2025
927
3.270
Why?
Esophagectomy
20
2024
136
3.260
Why?
Myeloid-Derived Suppressor Cells
6
2025
77
2.540
Why?
Sentinel Lymph Node Biopsy
23
2022
117
2.520
Why?
Gastrointestinal Stromal Tumors
10
2022
41
2.060
Why?
Neoadjuvant Therapy
15
2025
474
1.610
Why?
Sentinel Lymph Node
9
2022
49
1.590
Why?
Rectal Neoplasms
8
2024
159
1.570
Why?
Dendritic Cells
13
2019
507
1.530
Why?
T-Lymphocytes, Regulatory
11
2022
411
1.500
Why?
Pancreatic Neoplasms
15
2024
944
1.490
Why?
Neoplasm Recurrence, Local
19
2024
1156
1.430
Why?
Stomach Neoplasms
6
2025
128
1.360
Why?
Lymphatic Metastasis
20
2023
335
1.280
Why?
Neoplasm Staging
33
2025
1486
1.250
Why?
Tumor Escape
4
2017
50
1.140
Why?
Antineoplastic Combined Chemotherapy Protocols
10
2024
1996
1.100
Why?
Hyperthermia, Induced
4
2020
119
1.070
Why?
Humans
218
2026
145625
1.060
Why?
Sarcoma
8
2026
209
1.060
Why?
Colonic Neoplasms
7
2024
257
1.050
Why?
HIV-1
17
2025
911
1.040
Why?
Lymph Nodes
15
2023
511
1.030
Why?
Middle Aged
107
2026
36359
1.020
Why?
Anus Neoplasms
3
2024
33
1.010
Why?
Neoplasms
14
2025
2944
1.000
Why?
Aged
89
2026
26251
0.980
Why?
Peritoneal Neoplasms
4
2024
102
0.950
Why?
Hyperglycemia
3
2020
381
0.930
Why?
Retrospective Studies
57
2026
17291
0.930
Why?
Postoperative Complications
21
2025
2962
0.930
Why?
Intestinal Neoplasms
2
2024
31
0.930
Why?
Cytoreduction Surgical Procedures
5
2024
69
0.910
Why?
HIV Infections
21
2025
3210
0.880
Why?
CD4-Positive T-Lymphocytes
14
2025
1148
0.880
Why?
Prognosis
30
2025
4331
0.880
Why?
Laparoscopy
8
2024
474
0.870
Why?
Colorectal Neoplasms
8
2025
870
0.860
Why?
Intestine, Small
2
2024
160
0.830
Why?
Survival Rate
23
2025
2078
0.820
Why?
Male
121
2026
73014
0.810
Why?
Female
132
2026
79080
0.800
Why?
Mucosal-Associated Invariant T Cells
1
2024
39
0.790
Why?
Intestinal Mucosa
10
2021
666
0.770
Why?
Pancreaticoduodenectomy
7
2021
149
0.730
Why?
Lymph Node Excision
8
2022
173
0.720
Why?
Tretinoin
3
2023
114
0.720
Why?
Neoplasms, Second Primary
1
2023
103
0.700
Why?
Lymphocyte Activation
11
2018
1136
0.680
Why?
T-Lymphocytes
8
2024
2007
0.680
Why?
Pelvic Exenteration
4
2019
12
0.660
Why?
Gastrointestinal Microbiome
9
2025
767
0.650
Why?
Proto-Oncogene Proteins c-kit
5
2022
73
0.650
Why?
Radiosurgery
4
2020
398
0.620
Why?
Anastomotic Leak
4
2024
45
0.620
Why?
Adult
69
2026
40821
0.620
Why?
Survival Analysis
16
2022
1372
0.610
Why?
Splenectomy
1
2020
61
0.610
Why?
Chemoradiotherapy
6
2024
238
0.600
Why?
Pancreatic Cyst
2
2017
50
0.590
Why?
Piperazines
5
2014
367
0.580
Why?
Ipilimumab
2
2019
44
0.580
Why?
Myeloid Cells
3
2020
149
0.570
Why?
Spleen
6
2017
503
0.570
Why?
Ischemic Preconditioning
3
2024
47
0.570
Why?
Radiotherapy, Intensity-Modulated
2
2018
143
0.550
Why?
Granulocytes
2
2017
82
0.550
Why?
Pyrimidines
5
2014
530
0.540
Why?
Induction Chemotherapy
3
2024
87
0.530
Why?
Monocytes
2
2020
538
0.530
Why?
Leukocytes, Mononuclear
5
2021
585
0.530
Why?
Appendiceal Neoplasms
1
2017
28
0.520
Why?
Antineoplastic Agents
9
2024
2218
0.520
Why?
Combined Modality Therapy
15
2024
1269
0.500
Why?
Aged, 80 and over
28
2024
8351
0.500
Why?
Pylorus
1
2017
17
0.500
Why?
Gastric Outlet Obstruction
1
2017
12
0.500
Why?
Follow-Up Studies
20
2025
5397
0.490
Why?
Mucous Membrane
5
2024
129
0.490
Why?
CD8-Positive T-Lymphocytes
6
2024
929
0.490
Why?
Time-to-Treatment
4
2025
257
0.480
Why?
Neuromuscular Agents
1
2017
46
0.470
Why?
Soft Tissue Neoplasms
3
2022
133
0.470
Why?
Antineoplastic Agents, Immunological
1
2018
200
0.460
Why?
Botulinum Toxins, Type A
1
2017
60
0.460
Why?
Treatment Outcome
29
2026
11744
0.460
Why?
Head and Neck Neoplasms
5
2019
563
0.460
Why?
Leucovorin
2
2019
98
0.460
Why?
Lymphocytes, Tumor-Infiltrating
5
2024
155
0.440
Why?
Liver Neoplasms
6
2024
774
0.440
Why?
Vitamin B Complex
1
2014
39
0.420
Why?
Immune Tolerance
4
2016
384
0.410
Why?
Lymphocytes
3
2021
379
0.400
Why?
Salvage Therapy
2
2014
163
0.400
Why?
Esophagogastric Junction
4
2024
54
0.400
Why?
Minimally Invasive Surgical Procedures
6
2023
192
0.400
Why?
Pancreatectomy
5
2024
289
0.390
Why?
Melanoma, Experimental
3
2022
106
0.390
Why?
Pelvis
1
2014
129
0.390
Why?
Ear, External
1
2013
22
0.390
Why?
Mohs Surgery
1
2013
30
0.380
Why?
Up-Regulation
5
2025
840
0.380
Why?
Mutation
9
2025
4082
0.380
Why?
T-Lymphocytes, Helper-Inducer
4
2017
127
0.370
Why?
Microbiota
5
2024
724
0.370
Why?
Immunity, Innate
5
2025
843
0.370
Why?
B-Lymphocytes
4
2025
884
0.370
Why?
Biopsy
3
2023
1073
0.370
Why?
Abdominal Neoplasms
3
2025
48
0.360
Why?
Prospective Studies
22
2025
8087
0.360
Why?
Retroperitoneal Neoplasms
4
2026
27
0.360
Why?
Carcinoma, Squamous Cell
2
2014
627
0.350
Why?
Tumor Microenvironment
7
2025
745
0.350
Why?
Hematologic Diseases
1
2012
66
0.350
Why?
Anastomosis, Surgical
3
2024
161
0.350
Why?
Suppressor Factors, Immunologic
1
2011
4
0.350
Why?
Biomarkers, Tumor
6
2025
1334
0.340
Why?
Receptors, CCR5
3
2021
59
0.340
Why?
Cytokines
8
2021
2079
0.340
Why?
Cell Movement
6
2025
950
0.330
Why?
Dasatinib
2
2024
58
0.330
Why?
Surgical Wound Infection
1
2014
331
0.330
Why?
Conversion to Open Surgery
2
2020
22
0.310
Why?
Palliative Care
1
2019
1032
0.310
Why?
Thrombelastography
2
2024
181
0.310
Why?
Killer Cells, Natural
3
2025
481
0.310
Why?
Granzymes
2
2021
51
0.310
Why?
Esophageal Achalasia
2
2021
29
0.300
Why?
Gastrointestinal Hemorrhage
2
2022
133
0.300
Why?
Benzamides
5
2014
226
0.300
Why?
Homosexuality, Male
3
2021
231
0.300
Why?
Databases, Factual
7
2025
1481
0.300
Why?
Young Adult
20
2025
14240
0.300
Why?
Interferon-gamma
6
2019
780
0.300
Why?
Single Photon Emission Computed Tomography Computed Tomography
2
2019
15
0.290
Why?
Immunotherapy
5
2024
669
0.280
Why?
Butyrates
2
2021
65
0.280
Why?
Membrane Glycoproteins
3
2015
495
0.280
Why?
Interleukin-15
2
2021
96
0.280
Why?
Immunity, Mucosal
3
2016
97
0.270
Why?
Medical Oncology
4
2022
344
0.270
Why?
Barrett Esophagus
3
2020
172
0.270
Why?
Cell Differentiation
5
2016
1979
0.270
Why?
Neoplasm Metastasis
4
2025
693
0.270
Why?
Chemotherapy, Adjuvant
9
2023
429
0.270
Why?
Wounds and Injuries
4
2009
956
0.270
Why?
Interleukin-10
4
2025
310
0.270
Why?
Antigens, Neoplasm
3
2024
271
0.270
Why?
Inflammation Mediators
2
2018
507
0.260
Why?
Blood Preservation
2
2009
346
0.260
Why?
Disease-Free Survival
8
2019
777
0.260
Why?
Prostatic Neoplasms
1
2014
972
0.250
Why?
Nomograms
2
2019
59
0.250
Why?
General Surgery
2
2007
203
0.250
Why?
Paraneoplastic Syndromes
1
2007
14
0.250
Why?
Immunocompromised Host
1
2008
201
0.250
Why?
Dysbiosis
3
2021
184
0.250
Why?
Colon
3
2021
304
0.240
Why?
Cells, Cultured
9
2021
4112
0.240
Why?
Mice
25
2025
18266
0.240
Why?
Th2 Cells
2
2005
179
0.240
Why?
Splenic Neoplasms
1
2006
6
0.240
Why?
Lymphangioma
1
2006
9
0.240
Why?
Erythrocyte Transfusion
1
2008
225
0.240
Why?
Time Factors
12
2024
7079
0.240
Why?
Forkhead Transcription Factors
1
2007
208
0.240
Why?
Pelvic Neoplasms
3
2012
24
0.230
Why?
Population Surveillance
2
2021
477
0.230
Why?
Transplantation Immunology
1
2005
28
0.230
Why?
Ecotype
1
2025
15
0.230
Why?
Receptors, Cell Surface
2
2021
371
0.230
Why?
Macrophages, Peritoneal
3
2005
89
0.230
Why?
Mice, Inbred BALB C
6
2024
1244
0.230
Why?
Protein Tyrosine Phosphatase, Non-Receptor Type 22
1
2025
48
0.230
Why?
Vena Cava, Inferior
1
2026
79
0.230
Why?
Interleukin-1 Receptor-Associated Kinases
1
2025
41
0.220
Why?
Exome
2
2017
232
0.220
Why?
Signal Transduction
10
2025
5234
0.220
Why?
Mentors
1
2007
215
0.220
Why?
Nevus, Epithelioid and Spindle Cell
1
2005
14
0.220
Why?
Circulating Tumor DNA
1
2025
50
0.220
Why?
Neuroendocrine Tumors
2
2017
122
0.220
Why?
Catheter Ablation
4
2016
355
0.220
Why?
Cellular Microenvironment
1
2025
94
0.220
Why?
Computational Biology
3
2025
675
0.220
Why?
DNA-Activated Protein Kinase
1
2024
14
0.210
Why?
Culture Media, Conditioned
4
2011
112
0.210
Why?
Radiation Injuries
2
2021
149
0.210
Why?
Tumor Hypoxia
1
2024
7
0.210
Why?
Nevus, Pigmented
1
2005
35
0.210
Why?
Carcinoma, Pancreatic Ductal
2
2021
297
0.210
Why?
Virus Replication
5
2017
525
0.210
Why?
Metastasectomy
1
2024
19
0.210
Why?
Th1 Cells
2
2019
138
0.210
Why?
Macrophage Activation
1
2005
182
0.210
Why?
Gastrectomy
3
2025
162
0.210
Why?
Hepatectomy
3
2024
254
0.210
Why?
Mice, Nude
2
2024
665
0.200
Why?
Lymphangiogenesis
1
2004
27
0.200
Why?
B7-H1 Antigen
2
2024
245
0.200
Why?
Lymphocyte Count
5
2017
166
0.200
Why?
Cohort Studies
7
2025
6045
0.200
Why?
Carcinoma
2
2006
225
0.200
Why?
Interferon-alpha
3
2015
201
0.200
Why?
Ruminococcus
2
2021
7
0.200
Why?
In Vitro Techniques
5
2019
1041
0.200
Why?
Pseudomonas Infections
1
2025
229
0.200
Why?
Flow Cytometry
6
2017
1160
0.200
Why?
Paget Disease, Extramammary
1
2003
4
0.190
Why?
Immunophenotyping
3
2025
324
0.190
Why?
Enterobacteriaceae
2
2017
44
0.190
Why?
Esophageal Stenosis
1
2024
60
0.190
Why?
Cannabinoids
1
2025
181
0.190
Why?
Feces
4
2021
494
0.190
Why?
Erythrocytes
1
2009
749
0.190
Why?
Adolescent
15
2019
22451
0.190
Why?
Animals
28
2025
38030
0.190
Why?
Lymphoscintigraphy
2
2019
10
0.190
Why?
Bacteria
3
2018
766
0.190
Why?
Receptors, G-Protein-Coupled
2
2022
232
0.190
Why?
Intestines
2
2017
351
0.190
Why?
Lymphoid Tissue
3
2008
82
0.180
Why?
Transforming Growth Factor beta
4
2015
466
0.180
Why?
Protein-Energy Malnutrition
2
2003
7
0.180
Why?
Specialties, Surgical
1
2023
83
0.180
Why?
Lysophospholipids
1
2023
80
0.180
Why?
Epstein-Barr Virus Infections
1
2024
102
0.180
Why?
Cell Count
2
2017
315
0.180
Why?
Education, Medical, Graduate
1
2007
566
0.180
Why?
Salmonella typhimurium
2
2021
193
0.180
Why?
Cryosurgery
2
2019
46
0.180
Why?
Receptors, CXCR3
1
2022
17
0.180
Why?
Ampulla of Vater
2
2024
40
0.180
Why?
HIV Seropositivity
1
2022
117
0.180
Why?
Preoperative Care
3
2018
375
0.180
Why?
Chemokine CXCL9
1
2022
38
0.170
Why?
Chemokine CXCL10
1
2022
39
0.170
Why?
Imatinib Mesylate
5
2014
77
0.170
Why?
Patient Selection
3
2014
720
0.170
Why?
Cell Line, Tumor
7
2025
3538
0.170
Why?
Tomography, X-Ray Computed
6
2016
2766
0.170
Why?
Hematologic Neoplasms
1
2024
169
0.170
Why?
Esophagoscopy
2
2020
223
0.170
Why?
Critical Pathways
1
2022
104
0.170
Why?
Acinetobacter
1
2021
16
0.170
Why?
Germinal Center
2
2025
67
0.170
Why?
Carcinoma in Situ
1
2001
45
0.170
Why?
Seminoma
1
2021
20
0.160
Why?
ADAM10 Protein
1
2021
29
0.160
Why?
T-Lymphocytes, Cytotoxic
3
2022
180
0.160
Why?
Disease Progression
2
2022
2857
0.160
Why?
Glucose
3
2020
1051
0.160
Why?
Interleukin-2
5
2022
434
0.160
Why?
Gamma Rays
1
2021
56
0.160
Why?
Social Determinants of Health
1
2025
315
0.160
Why?
Epigenesis, Genetic
1
2025
705
0.160
Why?
Carcinoma, Lobular
1
2001
59
0.160
Why?
Carcinoma, Ductal, Breast
1
2001
91
0.160
Why?
Risk Factors
12
2024
10840
0.160
Why?
Delivery of Health Care
2
2021
942
0.160
Why?
Diarrhea
3
2008
190
0.160
Why?
Amyloid Precursor Protein Secretases
1
2021
80
0.160
Why?
Group II Phospholipases A2
1
2020
10
0.160
Why?
Bacterial Translocation
2
2019
51
0.160
Why?
Receptors, CCR
1
2020
6
0.160
Why?
Transcriptome
2
2025
1066
0.160
Why?
Interleukins
2
2019
247
0.160
Why?
Carcinoembryonic Antigen
2
2022
40
0.160
Why?
Software
1
2025
673
0.150
Why?
Protein Kinase Inhibitors
4
2024
982
0.150
Why?
Platelet Count
1
2020
94
0.150
Why?
Guidelines as Topic
2
2018
267
0.150
Why?
Neoplasms, Germ Cell and Embryonal
1
2021
76
0.150
Why?
Basophils
1
2020
52
0.150
Why?
Neutrophils
1
2025
1132
0.150
Why?
Lymphocyte Subsets
1
2020
79
0.150
Why?
Apoptosis
5
2021
2436
0.150
Why?
Histone Deacetylase Inhibitors
1
2021
218
0.150
Why?
Cell Proliferation
6
2021
2497
0.150
Why?
United States
14
2025
16041
0.150
Why?
Dacarbazine
4
2012
98
0.150
Why?
Scalp
1
2019
38
0.150
Why?
Gastric Bypass
1
2021
115
0.150
Why?
Sclerosing Solutions
1
2019
10
0.150
Why?
Argon Plasma Coagulation
1
2019
6
0.150
Why?
Leukocyte Count
1
2020
319
0.150
Why?
Germ-Free Life
1
2019
33
0.150
Why?
Sclerotherapy
1
2019
18
0.150
Why?
Palatine Tonsil
4
2025
55
0.140
Why?
CD4 Antigens
2
2011
135
0.140
Why?
Haploinsufficiency
1
2019
53
0.140
Why?
Surgeons
1
2023
337
0.140
Why?
Patient Care Planning
2
2016
170
0.140
Why?
Self Expandable Metallic Stents
1
2019
17
0.140
Why?
Stomach
3
2024
106
0.140
Why?
HLA-DR Antigens
2
2011
211
0.140
Why?
Nutritional Support
1
2019
39
0.140
Why?
Gram-Positive Bacteria
1
2019
48
0.140
Why?
Receptor, Platelet-Derived Growth Factor alpha
2
2022
54
0.140
Why?
Epithelial-Mesenchymal Transition
1
2021
218
0.140
Why?
Mastocytosis
1
2019
15
0.140
Why?
Photochemotherapy
1
2019
39
0.140
Why?
Postoperative Period
1
2020
344
0.140
Why?
Intestinal Perforation
1
2019
46
0.140
Why?
Decision Making
2
2019
987
0.140
Why?
Skin Pigmentation
1
2019
44
0.140
Why?
Gene Expression Regulation, Neoplastic
5
2025
1429
0.140
Why?
Environmental Restoration and Remediation
1
2018
8
0.140
Why?
Dilatation
1
2019
73
0.140
Why?
Gram-Negative Bacteria
1
2019
80
0.140
Why?
CTLA-4 Antigen
1
2019
105
0.140
Why?
Th17 Cells
1
2019
103
0.140
Why?
Tissue and Organ Procurement
1
2022
298
0.140
Why?
Intestinal Obstruction
1
2019
54
0.140
Why?
Esophagus
1
2020
260
0.140
Why?
Survivors
2
2015
521
0.140
Why?
Breast Neoplasms
2
2001
2411
0.140
Why?
Fibrosis
1
2021
568
0.140
Why?
Septins
1
2018
43
0.130
Why?
Brachytherapy
1
2019
132
0.130
Why?
Hospitals
2
2021
730
0.130
Why?
Oncogene Proteins v-abl
1
2017
5
0.130
Why?
Germ-Line Mutation
1
2019
180
0.130
Why?
Down-Regulation
1
2020
612
0.130
Why?
HIV
1
2019
249
0.130
Why?
Carcinoid Tumor
1
2017
21
0.130
Why?
Endoscopic Mucosal Resection
1
2018
40
0.130
Why?
Risk Assessment
4
2024
3678
0.130
Why?
Viral Tropism
1
2017
37
0.130
Why?
Food, Formulated
1
1997
16
0.130
Why?
Neurofibromin 1
1
2017
26
0.130
Why?
Common Bile Duct Neoplasms
1
2017
28
0.130
Why?
Venous Thromboembolism
2
2012
330
0.130
Why?
Liver
4
2016
1859
0.130
Why?
src-Family Kinases
1
2017
93
0.130
Why?
Deglutition Disorders
1
2019
159
0.130
Why?
Laser Therapy
1
2019
146
0.130
Why?
Enteral Nutrition
2
2010
212
0.120
Why?
Fatty Acids, Omega-3
1
1998
145
0.120
Why?
Gastric Emptying
1
2017
36
0.120
Why?
Chemotaxis, Leukocyte
2
2025
115
0.120
Why?
RNA Splicing Factors
1
2017
66
0.120
Why?
Arginine
1
1998
263
0.120
Why?
Disease Management
1
2021
649
0.120
Why?
Endoscopy, Gastrointestinal
1
2019
236
0.120
Why?
Analgesics, Opioid
1
2025
1158
0.120
Why?
Antibodies, Monoclonal, Humanized
1
2023
992
0.120
Why?
Oncogene Proteins, Fusion
1
2018
212
0.120
Why?
Digestive System Neoplasms
1
2016
9
0.120
Why?
Enzyme Inhibitors
1
2020
820
0.120
Why?
Hospitals, High-Volume
1
2016
49
0.120
Why?
Nutritional Status
1
2019
344
0.120
Why?
Proto-Oncogene Proteins B-raf
1
2018
230
0.120
Why?
Cancer Care Facilities
1
2016
48
0.120
Why?
Genes, erbB-1
1
2016
21
0.120
Why?
Antigen Presentation
1
2017
209
0.120
Why?
Polysaccharides, Bacterial
1
2016
69
0.120
Why?
Immunologic Memory
2
2016
369
0.120
Why?
Bystander Effect
1
2016
19
0.120
Why?
Digestive System Surgical Procedures
1
1997
111
0.120
Why?
Predictive Value of Tests
6
2024
2097
0.120
Why?
Lymphocyte Depletion
3
2013
135
0.120
Why?
Genital Neoplasms, Female
1
2017
100
0.120
Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2016
27
0.110
Why?
Mortality
1
2018
375
0.110
Why?
T-Lymphocyte Subsets
2
2024
415
0.110
Why?
Tomography, Emission-Computed, Single-Photon
1
2016
104
0.110
Why?
Enzyme-Linked Immunosorbent Assay
2
2008
845
0.110
Why?
Morbidity
3
2023
317
0.110
Why?
Exons
3
2019
361
0.110
Why?
Proto-Oncogene Proteins c-bcl-2
2
2021
237
0.110
Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
2
2015
56
0.110
Why?
Cystadenoma, Mucinous
1
2015
11
0.110
Why?
Cystadenocarcinoma, Mucinous
1
2015
12
0.110
Why?
Perioperative Care
1
2018
229
0.110
Why?
Adenoma
1
2017
209
0.110
Why?
Tumor Necrosis Factor-alpha
4
2018
1223
0.110
Why?
Randomized Controlled Trials as Topic
1
2002
1754
0.110
Why?
Phosphoproteins
1
2017
319
0.110
Why?
High-Throughput Nucleotide Sequencing
3
2025
538
0.110
Why?
Ileus
1
2014
13
0.110
Why?
Receptors, Ghrelin
1
2014
7
0.110
Why?
Postoperative Care
1
1997
292
0.110
Why?
Simian Acquired Immunodeficiency Syndrome
1
2015
93
0.110
Why?
Biomarkers
3
2024
4329
0.110
Why?
Vinblastine
2
2012
75
0.100
Why?
Membrane Proteins
1
2021
1130
0.100
Why?
Xenograft Model Antitumor Assays
4
2021
928
0.100
Why?
Viral Load
5
2018
525
0.100
Why?
Endosonography
1
2016
160
0.100
Why?
Tumor Cells, Cultured
4
2021
878
0.100
Why?
Ethanol
1
2019
629
0.100
Why?
Gastrointestinal Agents
1
2014
62
0.100
Why?
Quality of Life
3
2019
3187
0.100
Why?
Dietary Supplements
1
1998
586
0.100
Why?
Blood Cell Count
1
2013
56
0.100
Why?
Fluorouracil
2
2019
231
0.100
Why?
Gastrointestinal Tract
1
2016
203
0.100
Why?
Colectomy
3
2008
107
0.100
Why?
Tumor Burden
4
2022
326
0.100
Why?
Lung Neoplasms
2
2017
2674
0.100
Why?
Drug Resistance, Neoplasm
3
2016
889
0.100
Why?
Lipopolysaccharide Receptors
1
2013
88
0.090
Why?
Carcinoma, Hepatocellular
1
2016
369
0.090
Why?
RNA, Viral
3
2013
691
0.090
Why?
Anti-Inflammatory Agents
1
2016
473
0.090
Why?
Oligopeptides
1
2014
264
0.090
Why?
Gastrointestinal Neoplasms
1
2013
74
0.090
Why?
Pilot Projects
1
2018
1878
0.090
Why?
Sensitivity and Specificity
4
2015
1992
0.090
Why?
Side-Population Cells
1
2012
6
0.090
Why?
HIV Antibodies
1
2013
61
0.090
Why?
Chi-Square Distribution
3
2014
511
0.090
Why?
Ablation Techniques
1
2012
36
0.090
Why?
Cisplatin
2
2012
346
0.090
Why?
Genetic Predisposition to Disease
2
2019
2455
0.090
Why?
Mice, Knockout
4
2024
3121
0.090
Why?
Biological Therapy
1
2012
28
0.090
Why?
Registries
1
2021
2382
0.090
Why?
Aldehyde Dehydrogenase
1
2012
98
0.090
Why?
Hospital Mortality
2
2016
1037
0.090
Why?
Efficiency, Organizational
1
2013
142
0.090
Why?
Tertiary Care Centers
1
2013
194
0.090
Why?
RNA, Ribosomal, 16S
3
2019
507
0.090
Why?
ADP-ribosyl Cyclase 1
1
2011
43
0.090
Why?
Escherichia coli Infections
1
2012
125
0.090
Why?
Elective Surgical Procedures
1
2013
203
0.080
Why?
Colonic Pouches
1
2011
14
0.080
Why?
Proctocolectomy, Restorative
1
2011
22
0.080
Why?
Gene Expression Profiling
3
2025
1790
0.080
Why?
Toll-Like Receptors
2
2018
193
0.080
Why?
Ligands
2
2023
676
0.080
Why?
Macrophages
2
2001
1530
0.080
Why?
Multivariate Analysis
4
2016
1531
0.080
Why?
Cell Separation
2
2010
300
0.080
Why?
Extremities
2
2022
142
0.080
Why?
Endocytosis
1
2011
168
0.080
Why?
Cell Transformation, Neoplastic
1
2012
314
0.080
Why?
Toll-Like Receptor 8
1
2010
8
0.080
Why?
DNA Copy Number Variations
2
2025
189
0.080
Why?
Interleukin-23
1
2010
16
0.080
Why?
Patient Care Team
1
2016
700
0.080
Why?
Heparin
1
2012
246
0.080
Why?
Toll-Like Receptor 7
1
2010
43
0.080
Why?
Gastric Fistula
1
2010
9
0.080
Why?
Cutaneous Fistula
1
2010
17
0.080
Why?
Antibodies, Neutralizing
1
2013
346
0.080
Why?
Antigens, CD
2
2015
559
0.080
Why?
Caspase 3
1
2010
240
0.080
Why?
Vascular Surgical Procedures
1
2013
341
0.070
Why?
Viremia
1
2010
158
0.070
Why?
Colitis, Ulcerative
1
2011
142
0.070
Why?
Escherichia coli
1
2014
831
0.070
Why?
Diagnosis, Differential
3
2015
1500
0.070
Why?
Antiviral Agents
1
2015
774
0.070
Why?
Rosaniline Dyes
3
2007
15
0.070
Why?
Mice, Inbred C57BL
5
2021
6021
0.070
Why?
Odds Ratio
3
2019
1070
0.070
Why?
Cell Transplantation
1
2009
39
0.070
Why?
Double-Blind Method
4
2014
2064
0.070
Why?
Referral and Consultation
1
2016
878
0.070
Why?
Immunoglobulins
2
2023
162
0.070
Why?
Genomics
2
2025
851
0.070
Why?
Paracrine Communication
1
2009
67
0.070
Why?
Radiotherapy, Conformal
1
2009
75
0.070
Why?
Phenotype
5
2019
3186
0.070
Why?
Receptors, Antigen, T-Cell
2
2024
676
0.070
Why?
Hyalin
1
2008
3
0.070
Why?
Leukocyte Reduction Procedures
1
2008
29
0.070
Why?
Dermatofibrosarcoma
1
2008
7
0.070
Why?
Prosthesis Implantation
1
2010
155
0.070
Why?
Neoplastic Stem Cells
1
2012
402
0.070
Why?
ROC Curve
2
2024
613
0.070
Why?
Gastrostomy
1
2010
123
0.070
Why?
Age Factors
3
2019
3321
0.070
Why?
Carcinoma, Non-Small-Cell Lung
1
2017
1194
0.070
Why?
Interleukin-4
2
2007
207
0.070
Why?
ras Proteins
1
2009
148
0.070
Why?
DNA Mutational Analysis
3
2016
409
0.070
Why?
Chemokine CXCL12
1
2008
85
0.070
Why?
Neoplastic Cells, Circulating
1
2008
81
0.070
Why?
Kaplan-Meier Estimate
3
2019
959
0.070
Why?
Programmed Cell Death 1 Receptor
2
2023
268
0.060
Why?
Logistic Models
4
2016
2112
0.060
Why?
Interleukin-3 Receptor alpha Subunit
1
2007
17
0.060
Why?
Case-Control Studies
3
2024
3633
0.060
Why?
Interleukin-1beta
2
2019
394
0.060
Why?
Interleukin-2 Receptor alpha Subunit
1
2007
82
0.060
Why?
Career Mobility
1
2007
68
0.060
Why?
Kidney Failure, Chronic
1
2013
582
0.060
Why?
Deoxycytidine
1
2008
219
0.060
Why?
Phylogeny
2
2024
921
0.060
Why?
Interleukin-6
4
1999
782
0.060
Why?
alpha-Defensins
1
2006
11
0.060
Why?
DNA, Bacterial
2
2019
319
0.060
Why?
Length of Stay
3
2019
1342
0.060
Why?
Immunohistochemistry
5
2008
1709
0.060
Why?
New York
2
2023
127
0.060
Why?
Laparotomy
1
2007
109
0.060
Why?
Anticoagulants
1
2012
743
0.060
Why?
Neoplasms, Unknown Primary
1
2006
20
0.060
Why?
Watchful Waiting
2
2018
90
0.060
Why?
History, 20th Century
1
2007
330
0.060
Why?
Vascular Patency
1
2026
115
0.060
Why?
Liquid Biopsy
1
2025
16
0.060
Why?
Blood Transfusion
1
2009
393
0.060
Why?
Pandemics
2
2025
1700
0.060
Why?
Lymphocyte Culture Test, Mixed
1
2005
49
0.060
Why?
Collagen
1
2008
460
0.060
Why?
Interleukin-17
2
2019
121
0.060
Why?
Critical Care
1
2012
700
0.060
Why?
Proto-Oncogene Proteins
1
2009
615
0.060
Why?
Cell Division
2
2005
735
0.060
Why?
Neoplasm Proteins
2
2024
443
0.060
Why?
Lipopolysaccharides
1
2009
861
0.060
Why?
Immunity, Cellular
1
2007
277
0.060
Why?
Quality Control
1
2025
162
0.050
Why?
Culture Media
1
2005
160
0.050
Why?
Thoracic Neoplasms
1
2005
40
0.050
Why?
Endoscopic Ultrasound-Guided Fine Needle Aspiration
2
2016
62
0.050
Why?
Mice, Inbred Strains
1
2005
384
0.050
Why?
Chromones
1
2024
43
0.050
Why?
Nitric Oxide
2
2001
883
0.050
Why?
Chemotherapy, Cancer, Regional Perfusion
1
2024
30
0.050
Why?
Obesity, Morbid
1
2008
284
0.050
Why?
Faculty, Medical
1
2007
305
0.050
Why?
Myeloid Cell Leukemia Sequence 1 Protein
1
2024
39
0.050
Why?
RNA, Messenger
2
2005
2783
0.050
Why?
Morpholines
1
2024
130
0.050
Why?
Azepines
1
2024
104
0.050
Why?
Surgical Procedures, Operative
1
2006
271
0.050
Why?
Pregnancy Complications, Neoplastic
1
2004
64
0.050
Why?
Age of Onset
1
2025
557
0.050
Why?
Carcinoma, Renal Cell
1
2026
229
0.050
Why?
Quality Improvement
1
2012
1325
0.050
Why?
Fellowships and Scholarships
1
2007
353
0.050
Why?
Monitoring, Immunologic
1
2023
25
0.050
Why?
Toll-Like Receptor 4
1
2005
277
0.050
Why?
Neoplasm Invasiveness
2
2018
503
0.050
Why?
Receptors, Lysophosphatidic Acid
1
2023
40
0.050
Why?
Constriction, Pathologic
1
2024
238
0.050
Why?
Leadership
1
2007
410
0.050
Why?
Multilocus Sequence Typing
1
2022
16
0.050
Why?
Herpesvirus 4, Human
1
2024
172
0.050
Why?
Antigens, CD1
2
2015
59
0.050
Why?
Chemoradiotherapy, Adjuvant
1
2023
44
0.050
Why?
Triazoles
1
2024
190
0.050
Why?
Pseudomonas aeruginosa
1
2025
392
0.050
Why?
Body Weight
4
2003
964
0.050
Why?
Axilla
2
2017
51
0.050
Why?
Receptors, KIR
1
2023
123
0.040
Why?
Thymus Gland
1
2023
310
0.040
Why?
Uveal Neoplasms
1
2021
16
0.040
Why?
Corticosterone
1
2003
241
0.040
Why?
Child
4
2019
22638
0.040
Why?
Technetium
1
2001
10
0.040
Why?
Injections, Intradermal
1
2001
13
0.040
Why?
Dietary Proteins
1
2003
135
0.040
Why?
Cell- and Tissue-Based Therapy
1
2022
78
0.040
Why?
Hypoglycemia
1
2007
489
0.040
Why?
Kidney Neoplasms
1
2026
417
0.040
Why?
Technetium Tc 99m Sulfur Colloid
1
2001
6
0.040
Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2023
330
0.040
Why?
NF-kappa B
1
2005
674
0.040
Why?
Drug-Related Side Effects and Adverse Reactions
2
2019
266
0.040
Why?
Radionuclide Imaging
1
2001
116
0.040
Why?
Propionates
1
2021
39
0.040
Why?
Leptin
1
2003
247
0.040
Why?
Remission, Spontaneous
1
2021
39
0.040
Why?
Mediastinoscopy
1
2021
5
0.040
Why?
Molecular Targeted Therapy
1
2024
446
0.040
Why?
Acetates
1
2021
78
0.040
Why?
Biopsy, Needle
1
2001
182
0.040
Why?
Neoplasm Transplantation
3
2012
238
0.040
Why?
Ephrin-B2
1
2021
45
0.040
Why?
Glycoproteins
2
2015
355
0.040
Why?
Cholangiography
1
2000
10
0.040
Why?
Probability
1
2001
308
0.040
Why?
Workload
1
2002
169
0.040
Why?
Precision Medicine
2
2016
462
0.040
Why?
Acetylation
1
2021
262
0.040
Why?
Positron-Emission Tomography
3
2008
342
0.040
Why?
Socioeconomic Factors
1
2025
1323
0.040
Why?
Veterans
1
2013
1647
0.040
Why?
Thoracoscopy
1
2020
60
0.040
Why?
Tissue Banks
1
2020
17
0.040
Why?
DNA Methylation
1
2025
721
0.040
Why?
Radiopharmaceuticals
1
2001
210
0.040
Why?
Statistics, Nonparametric
2
2012
423
0.040
Why?
Esophageal Mucosa
1
2020
22
0.040
Why?
Early Detection of Cancer
1
2025
501
0.040
Why?
Regression Analysis
2
2019
994
0.040
Why?
Genome, Bacterial
1
2021
122
0.040
Why?
Quality of Health Care
3
2012
692
0.040
Why?
Interleukin-12 Subunit p35
1
2019
3
0.040
Why?
Coloring Agents
2
2012
88
0.040
Why?
Body Mass Index
1
2008
2446
0.040
Why?
Image-Guided Biopsy
1
2019
41
0.040
Why?
Fibroblasts
1
2005
1033
0.040
Why?
Eating
2
2003
386
0.040
Why?
Paclitaxel
2
2012
258
0.040
Why?
Analysis of Variance
2
2012
1293
0.040
Why?
Imaging, Three-Dimensional
2
2016
578
0.040
Why?
Radiography
2
2016
856
0.040
Why?
Margins of Excision
1
2019
54
0.040
Why?
Tight Junctions
1
2019
87
0.040
Why?
Organ Size
2
2016
463
0.040
Why?
Montana
1
2018
18
0.040
Why?
Keratins
2
2010
57
0.030
Why?
United States Environmental Protection Agency
1
2018
28
0.030
Why?
Preoperative Period
1
2019
150
0.030
Why?
Mitogens
1
1998
55
0.030
Why?
Patient Satisfaction
1
2022
698
0.030
Why?
Immunotherapy, Adoptive
1
2022
356
0.030
Why?
Interleukin-18
1
2019
234
0.030
Why?
Colony Count, Microbial
1
2018
90
0.030
Why?
Evidence-Based Medicine
1
2002
727
0.030
Why?
Cachexia
1
1999
74
0.030
Why?
Pedigree
1
2019
507
0.030
Why?
Tumor Suppressor Protein p53
1
2022
530
0.030
Why?
Principal Component Analysis
1
2018
192
0.030
Why?
Jejunostomy
1
1997
13
0.030
Why?
Perioperative Period
1
2017
69
0.030
Why?
Dinoprostone
1
1998
179
0.030
Why?
DNA-Binding Proteins
1
2024
1467
0.030
Why?
Ki-67 Antigen
1
2017
119
0.030
Why?
Antigen-Presenting Cells
1
2017
161
0.030
Why?
Occipital Bone
1
2017
18
0.030
Why?
Liver Circulation
1
2016
12
0.030
Why?
Parotid Gland
1
2017
17
0.030
Why?
Candidiasis
1
1997
64
0.030
Why?
Femoral Fractures
1
1998
84
0.030
Why?
Ultrasonography, Doppler, Color
1
2016
36
0.030
Why?
DNA, Ribosomal
1
2017
83
0.030
Why?
Operative Time
1
2017
192
0.030
Why?
Infection Control
1
1998
174
0.030
Why?
ErbB Receptors
1
2020
636
0.030
Why?
Radiotherapy Dosage
2
2008
289
0.030
Why?
Robotic Surgical Procedures
1
2019
204
0.030
Why?
Neck
1
2017
107
0.030
Why?
Costs and Cost Analysis
1
1997
216
0.030
Why?
Sexual and Gender Minorities
1
2021
268
0.030
Why?
Superinfection
1
2016
5
0.030
Why?
Models, Anatomic
1
2016
87
0.030
Why?
Adaptor Proteins, Signal Transducing
1
2019
427
0.030
Why?
Receptors, CXCR5
1
2016
29
0.030
Why?
Hydrogen Peroxide
1
1998
337
0.030
Why?
Radiotherapy, Adjuvant
2
2008
222
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2008
973
0.030
Why?
Sequence Analysis, RNA
1
2018
441
0.030
Why?
Host Specificity
1
2016
33
0.030
Why?
Histones
1
2021
670
0.030
Why?
Incidental Findings
1
2016
81
0.030
Why?
Primary Cell Culture
1
2016
172
0.030
Why?
Protein Binding
1
2022
2239
0.030
Why?
Cluster Analysis
1
2017
494
0.030
Why?
Asymptomatic Diseases
1
2016
102
0.030
Why?
Prevotella
1
2015
27
0.030
Why?
Virion
1
2015
112
0.030
Why?
Macaca mulatta
1
2015
187
0.030
Why?
CD40 Antigens
1
2015
67
0.030
Why?
Autoimmune Diseases
1
2019
466
0.030
Why?
Sexual Behavior
1
2019
489
0.030
Why?
Endoscopy, Digestive System
1
2016
141
0.030
Why?
HEK293 Cells
1
2017
746
0.030
Why?
Protein-Tyrosine Kinases
1
1998
429
0.030
Why?
Qualitative Research
1
2022
1720
0.030
Why?
Cross-Sectional Studies
2
2017
5875
0.030
Why?
Cell Cycle
1
2017
595
0.030
Why?
Glucocorticoids
1
1999
536
0.030
Why?
Feasibility Studies
2
2010
1125
0.030
Why?
Mitotic Index
1
2014
24
0.030
Why?
Cattle
1
2016
938
0.030
Why?
Nausea
1
2014
111
0.030
Why?
Sequence Analysis, DNA
1
2017
771
0.030
Why?
Vomiting
1
2014
131
0.030
Why?
Patient Readmission
1
2019
771
0.020
Why?
Colitis
1
2016
280
0.020
Why?
Phosphorylation
1
1998
1717
0.020
Why?
Caspase 1
1
2014
145
0.020
Why?
CD4 Lymphocyte Count
1
2014
280
0.020
Why?
Genes, Immunoglobulin Heavy Chain
1
2013
10
0.020
Why?
Cell Lineage
1
2015
375
0.020
Why?
Autoantigens
1
2016
426
0.020
Why?
Reproducibility of Results
1
2021
3396
0.020
Why?
Magnetic Resonance Imaging
2
2008
3917
0.020
Why?
HIV Envelope Protein gp120
1
2013
55
0.020
Why?
Retinal Dehydrogenase
1
2012
27
0.020
Why?
Aldehyde Oxidoreductases
1
2012
27
0.020
Why?
Inflammation
2
2019
2915
0.020
Why?
Immunoglobulin Heavy Chains
1
2013
83
0.020
Why?
Clinical Decision-Making
1
2016
364
0.020
Why?
Antibody Specificity
1
2013
181
0.020
Why?
Practice Guidelines as Topic
1
2020
1581
0.020
Why?
International Agencies
1
2012
30
0.020
Why?
AIDS Vaccines
1
2013
53
0.020
Why?
Endarterectomy, Carotid
1
2013
63
0.020
Why?
Adoptive Transfer
1
2013
197
0.020
Why?
Thoracotomy
1
2012
87
0.020
Why?
Response Elements
1
2012
84
0.020
Why?
Hemorrhage
1
1998
824
0.020
Why?
Sequence Homology, Amino Acid
1
2013
382
0.020
Why?
Homeostasis
1
2016
646
0.020
Why?
Confidence Intervals
1
2012
328
0.020
Why?
Neoplasm Grading
1
2013
313
0.020
Why?
Isoenzymes
1
2012
294
0.020
Why?
APACHE
1
2012
67
0.020
Why?
Mice, SCID
1
2012
360
0.020
Why?
Receptors, HIV
1
2011
23
0.020
Why?
Calcium
1
1998
1181
0.020
Why?
Blood Coagulation Tests
1
2012
72
0.020
Why?
Internship and Residency
1
2002
1269
0.020
Why?
Gene Silencing
1
2012
200
0.020
Why?
Species Specificity
1
2013
542
0.020
Why?
Drug Administration Schedule
1
2013
782
0.020
Why?
Aortic Aneurysm, Abdominal
1
2013
162
0.020
Why?
Bone Marrow
1
2013
308
0.020
Why?
Interleukin-8
1
2012
268
0.020
Why?
Gene Expression
1
2016
1461
0.020
Why?
Clinical Competence
1
2019
1261
0.020
Why?
Models, Animal
1
2013
386
0.020
Why?
Single-Blind Method
1
2012
312
0.020
Why?
Genes, bcl-2
1
2010
21
0.020
Why?
Risk
1
2013
917
0.020
Why?
Cell Communication
1
2013
327
0.020
Why?
Mice, Inbred NOD
1
2012
598
0.020
Why?
Cell Survival
1
2014
1102
0.020
Why?
CA-19-9 Antigen
1
2010
36
0.020
Why?
Proportional Hazards Models
1
2014
1318
0.020
Why?
Universities
1
2013
450
0.020
Why?
Gastroscopy
1
2010
18
0.020
Why?
RNA, Small Interfering
1
2012
630
0.020
Why?
Staining and Labeling
1
2010
148
0.020
Why?
Factor Xa Inhibitors
1
2012
194
0.020
Why?
Incidence
1
1996
2910
0.020
Why?
Chronic Disease
1
2015
1824
0.020
Why?
Polymorphism, Restriction Fragment Length
1
2009
57
0.020
Why?
Keratin-20
1
2008
1
0.020
Why?
N-Acetylgalactosaminyltransferases
1
2008
5
0.020
Why?
Hepatic Veno-Occlusive Disease
1
2008
12
0.020
Why?
Amino Acid Sequence
1
2013
2088
0.020
Why?
Renal Dialysis
1
2013
458
0.020
Why?
Chloroquine
1
2009
54
0.020
Why?
Prostheses and Implants
1
2010
137
0.020
Why?
Liver Regeneration
1
2008
41
0.020
Why?
Dose-Response Relationship, Radiation
1
2008
141
0.020
Why?
Chemokine CX3CL1
1
2008
25
0.020
Why?
Reference Standards
1
2009
176
0.020
Why?
Immunoglobulin G
1
2013
899
0.020
Why?
Device Removal
1
2010
149
0.020
Why?
Molecular Sequence Data
1
2013
2835
0.020
Why?
Capecitabine
1
2008
56
0.020
Why?
Premedication
1
2008
45
0.020
Why?
Antigens, CD34
1
2008
89
0.020
Why?
Program Evaluation
1
2012
945
0.020
Why?
Proto-Oncogene Proteins c-met
1
2008
76
0.020
Why?
Proto-Oncogene Proteins p21(ras)
1
2009
250
0.020
Why?
Antimetabolites, Antineoplastic
1
2008
108
0.020
Why?
Models, Molecular
1
2013
1571
0.020
Why?
Mice, Transgenic
1
2013
2131
0.020
Why?
Sex Factors
1
2013
2101
0.020
Why?
Quinazolines
1
2009
267
0.020
Why?
Remission Induction
1
2008
308
0.020
Why?
Acute Disease
2
2003
1033
0.020
Why?
Swine
1
2010
821
0.020
Why?
DNA Primers
1
2008
487
0.020
Why?
Body Composition
2
2003
686
0.020
Why?
Lewis X Antigen
1
2006
5
0.020
Why?
Cytotoxicity, Immunologic
1
2007
224
0.020
Why?
Anti-Infective Agents
1
2009
234
0.010
Why?
Epitopes, T-Lymphocyte
1
2007
175
0.010
Why?
Polymerase Chain Reaction
1
2009
1030
0.010
Why?
Whole Body Imaging
1
2006
29
0.010
Why?
Gene Expression Regulation
1
2015
2591
0.010
Why?
Disease Models, Animal
1
2016
4565
0.010
Why?
Fluorescent Dyes
1
2007
340
0.010
Why?
Microscopy, Fluorescence
1
2006
403
0.010
Why?
Radiotherapy
1
2006
209
0.010
Why?
Base Sequence
1
2008
2119
0.010
Why?
Infant
1
2019
10093
0.010
Why?
Patient Discharge
1
2011
991
0.010
Why?
Pregnancy Trimester, Third
1
2004
116
0.010
Why?
Specific Pathogen-Free Organisms
1
2003
58
0.010
Why?
Adrenalectomy
1
2003
68
0.010
Why?
Appetite Regulation
1
2003
31
0.010
Why?
Drug Implants
1
2003
83
0.010
Why?
Colorado
1
2013
4588
0.010
Why?
Work Schedule Tolerance
1
2002
51
0.010
Why?
Random Allocation
1
2003
365
0.010
Why?
Personnel Staffing and Scheduling
1
2002
100
0.010
Why?
Cycloheximide
1
2001
42
0.010
Why?
Dactinomycin
1
2001
24
0.010
Why?
Peritoneum
1
2001
44
0.010
Why?
Mice, Inbred C3H
1
2001
252
0.010
Why?
Coculture Techniques
1
2001
244
0.010
Why?
Continuity of Patient Care
1
2002
297
0.010
Why?
Mifepristone
1
1999
45
0.010
Why?
Hormone Antagonists
1
1999
32
0.010
Why?
Mice, Inbred DBA
1
1999
185
0.010
Why?
Candida albicans
1
1997
62
0.010
Why?
Dose-Response Relationship, Drug
1
2001
2018
0.010
Why?
Obesity
1
2008
3123
0.010
Why?
RNA
1
2001
925
0.010
Why?
Injury Severity Score
1
1996
571
0.010
Why?
Attitude of Health Personnel
1
2002
1212
0.010
Why?
Pregnancy
1
2004
7217
0.010
Why?
Kidney
1
1997
1491
0.000
Why?
McCarter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)